Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed5
Other1

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT05617014Enrolling By Invitation
Alzheimer's Disease Neuroimaging Initiative 4
Alzheimer DiseaseDementiaMild Cognitive Impairment
PrincipalinvestigatorStart date: 2023-06-09
NCT04004767Completed
TRC-PAD Program: In-Clinic Trial-Ready Cohort
Alzheimer DiseaseDementiaPreclinical Alzheimer's Disease+1 more
PrincipalinvestigatorStart date: 2019-06-04
NCT02720445Phase 2Completed
Memory Improvement Through Nicotine Dosing (MIND) Study
Mild Cognitive Impairment
StudydirectorStart date: 2017-02-22
NCT02854033Completed
Alzheimer's Disease Neuroimaging Initiative 3
Alzheimer's Disease (AD)Mild Cognitive Impairment (MCI)
PrincipalinvestigatorStart date: 2016-12-02
NCT01767909Phase 2/3Completed
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
StudydirectorStart date: 2014-01-08
NCT01687153Completed
A Study of Brain Aging in Vietnam War Veterans
Alzheimer's DiseaseMild Cognitive ImpairmentPost Traumatic Stress Disorder+1 more
Principalinvestigator

Research Network

Collaboration Network

14 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ronald Petersen, MD, PhD

Mayo Clinic

Similar
3 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentAlzheimer DiseaseAlzheimer's Disease (AD)+3 more

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+5 more
Collaborated on 2 trials
Similarity Score68%

Michael W. Weiner, MD

University of California, San Francisco

Similar
4 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentAlzheimer DiseaseAlzheimer's Disease (AD)+2 more

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+5 more
Collaborated on 2 trials
Similarity Score58%

Reisa Sperling, MD

Brigham and Women's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Alzheimer DiseaseDementiaPreclinical Alzheimer's Disease+1 more

Worked with same sponsors:

Alzheimer's Clinical Trials ConsortiumAlzheimer's Therapeutic Research Institute+4 more
Collaborated on 1 trial
Similarity Score44%

Jeffrey Cummings, MD

Cleveland Clinic Lou Ruvo Center for Brain Health

Moderately Similar
1 trials

Shared therapeutic areas:

Alzheimer DiseaseDementiaPreclinical Alzheimer's Disease+1 more

Worked with same sponsors:

Alzheimer's Clinical Trials ConsortiumAlzheimer's Therapeutic Research Institute+4 more
Collaborated on 1 trial
Similarity Score44%

Suzanne Craft, PhD

Wake Forest University Health Sciences

Moderately Similar
11 trials

Shared therapeutic areas:

Mild Cognitive ImpairmentAlzheimer DiseaseAmnestic Mild Cognitive Impairment

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+2 more
Collaborated on 1 trial
Similarity Score34%

Michael Weiner, MD

University of California, San Francisco

Moderately Similar
3 trials

Shared therapeutic areas:

Alzheimer DiseaseDementiaMild Cognitive Impairment

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+2 more
Collaborated on 1 trial
Similarity Score34%

Ronald Peterson, MD, PHD

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Alzheimer's Disease (AD)Mild Cognitive Impairment

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+2 more
Collaborated on 1 trial
Similarity Score24%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Stress Disorders, Post-TraumaticAlzheimer DiseaseDementia+2 more
Similarity Score17%

Paul Newhouse, MD

Vanderbilt University

Related
1 trials

Shared therapeutic areas:

Mild Cognitive Impairment

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+2 more
Collaborated on 1 trial
Similarity Score14%

Eric M Wassermann, M.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
20 trials

Shared therapeutic areas:

Brain Injuries, TraumaticAlzheimer DiseaseDementia+1 more

Worked with same sponsors:

United States Department of Defense
Similarity Score13%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05617014PrincipalInvestigator

Alzheimer's Disease Neuroimaging Initiative 4

Alzheimer DiseaseDementiaMild Cognitive Impairment
Enrolling By Invitation
NCT04004767PrincipalInvestigator

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Alzheimer DiseaseDementiaPreclinical Alzheimer's Disease+1 more
Completed
NCT02720445Phase 2StudyDirector

Memory Improvement Through Nicotine Dosing (MIND) Study

Mild Cognitive Impairment
Completed
NCT02854033PrincipalInvestigator

Alzheimer's Disease Neuroimaging Initiative 3

Alzheimer's Disease (AD)Mild Cognitive Impairment (MCI)
Completed
NCT01767909Phase 2/3StudyDirector

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Completed
NCT01687153PrincipalInvestigator

A Study of Brain Aging in Vietnam War Veterans

Alzheimer's DiseaseMild Cognitive ImpairmentPost Traumatic Stress Disorder+1 more
Completed

All 6 trials loaded